TGFB1 and neoplasm: Nevertheless, a number of studies still showed favorable survival outcomes in cancer patients after anti-TGF-β therapy, suggesting a possible relationship between the efficacy of TGF-β-targeting drugs and the tumor context and the level of their bioavailability.